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Abstract
Background The medial pivot TKA design was introduced
in the 1990s. These are fixed-bearing, medial-conforming
implants with virtually no translation in the medial part of
the knee, in contrast to the flat lateral part of the insert
allowing for translation similar to the native knee during
flexion and extension. Most primary TKAs performed in
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Norway and Australia are cruciate-retaining. All of the
medial pivot implants in our study are cruciate-sacrificing
but without a post-cam mechanism. The medial pivot im-
plant design was developed to more closely mimic native
knee motion, in the hope of improving function, and not
primarily as a more constrained knee for difficult cases. In
the past 10 to 12 years, a second-generation medial-pivot
design has emerged, but there are no larger registry studies
on the survival of these implants. Both cruciate-retaining
and medial pivot designs are reported in the Australian and
Norwegian registries, allowing for large-scale, comparative
survivorship studies.
Questions/purposes (1) Is there any difference in survival
between the medial pivot design and the three most com-
monly used cruciate-retaining TKA designs? (2) Is there
any difference in survival among the different medial pivot
implant designs? (3) What are the main indications for
revision of medial pivot TKAs?
Methods Registry data from the Australian Orthopaedic
Association National Joint Replacement Registry and
Norwegian Arthroplasty Register from 2005 until the end of
2017 were used to compare the five different brands of
medial pivot TKA designs (total primary TKAs assessed:
6310). InAustralia, the study group ofmedial pivot implants
represented 9% (6012 of 72,477) of the total number of
cemented/hybrid TKAs without patellar resurfacing; 345
had cementless femoral components. In Norway, the study
group represented 1% (298 of 47,820) of the total number of
TKAs with cemented tibias without patellar resurfacing; all
had cemented femoral components. The control group
consisted of the three most commonly used cruciate-
retaining TKA designs (n = 70,870; Australia n = 54,554;
Norway n = 16,316). All TKAs used a fixed-bearing,
cemented tibial component and did not involve patella
resurfacing. Kaplan-Meier survival analysis was assessed to
estimate survivorship. We compared the groups by calcu-
lating the hazard ratios (HR) using Cox regression adjusted
for age, gender and preoperative diagnosis with 95% CI. To
answer our third question, we calculated the percentage of
each revision indication from the total number of revisions in
each group, and used a Cox regression analysis to compare
revision causes and HRs. Analyses were performed sepa-
rately by each registry. Accounting for competing risks
(Fine and Gray) did not alter our findings [12].
Results After controlling for potential confounding vari-
ables such as gender, age and preoperative diagnosis, we
found an increased revision risk for the medial pivot
compared with cruciate-retaining TKA designs in Australia
(HR 1.4 [95% CI 1.2 to 1.7]; p < 0.001), but not in Norway
(HR 1.5 [95% CI 0.9 to 2.4]; p = 0.1). Two brands of the
medial pivot design reported to the AOANJRR showed an
increased risk of revision compared with cruciate-retaining
designs: the Advance® II MP (HR 1.7 [95% CI 1.2 to 2.6];
p = 0.004) and the GMK® Sphere (HR 2.0 [95% CI 1.5 to
2.6]; p < 0.001), whereas the MRK™ (HR 0.7 [95% CI 0.4
to 1.5]; p = 0.4), the Evolution®MP (HR 1.4 [95%CI 1.0 to
1.9]; p = 0.06) and the SAIPH® (HR 0.9 [95% CI 0.5 to
1.5]; p = 0.7) showed no difference. The most common
reasons for revision of medial pivot implants in Australia
were infection (27%), pain alone (19%), patellar erosion
(13%), loosening/lysis (12%); in Norway the primary
indications were loosening/lysis (28%), instability (28%),
malalignment (11%) and pain alone (11%).
Conclusions The medial pivot TKA design as a group
had a higher revision rate than cruciate-retaining fixed-
bearing controls in TKA performed without patellar com-
ponent resurfacing. By brand, the Advance II MP and the
GMK Sphere had inferior survivorship, whereas the MRK,
the SAIPH and the Evolution MP had no differences in
survivorship compared with cruciate-retaining controls. In
Australia, TKAs with the medial pivot design without pa-
tella resurfacing had a higher rate of revisions for instability,
malalignment, and patella erosion. In Norway, there was an
increased risk of revision for lysis and loosening compared
with the cruciate-retaining design. Several of these implants
had short follow-up in this study. Further registry studies
with longer follow up are therefore necessary.
Level of Evidence Level III, therapeutic study.
Introduction
TKA is a generally effective way to treat gonarthritis. Still,
not all patients achieve the desired result of decreased pain
and increased function, and in some studies, as many as
20% are dissatisfied [3, 4]. Implants also perform differ-
ently with respect to survivorship, and the prosthesis de-
sign may contribute to these variations. Although there
are a variety of prosthetic designs, primary TKA implants
can be broadly classified into cruciate-retaining and
posterior-stabilized implants [6]. Studies suggest that after
TKA, there may be paradoxical motion of the lateral
femoral condyle, and instead of femoral rollback during
flexion, as occurs in the native knee [20], there may be
anterior femoral translation [10]. This may lead to a sen-
sation of instability, reduced quadriceps strength, and re-
duced flexion range of the knee [8-10, 35].
In the 1990s, the medial pivot design was introduced
[19]. The medial pivot design tries to mimic the in vivo
kinematics of the native knee. These fixed bearing implants
have a medial conforming articulation, similar to a ball and
socket. In the lateral compartment, the tibial insert isflat, and
together with laxity of the lateral collateral ligament, theo-
retically allows natural femoral rollback during kneeflexion.
All the medial pivot implants in our study are also cruciate-
sacrificing but without a post-cam mechanism [25, 27-29,
42]. The first TKA with a medial pivot design was the
Medial Rotation Knee (MRK™, MatOrtho, Surrey, UK)
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which was introduced in 1994, followed by the Advance®
Medial-Pivot Knee in 1998 (Wright Medical Group Inc,
Memphis, TN, USA) [1, 25]. A second generation of pros-
theses further developed the medial pivot theme, including
the Evolution® Medial-Pivot Knee (MicroPort Orthopedics
Inc, Arlington, TN, USA [42]), the SAIPH® Knee System
(MatOrtho [28]) and the GMK® Sphere (Medacta
International AG, Castel San Pietro, Switzerland [29]). As
medial pivot implants have increased in popularity, the
Australian Orthopaedic Association National Joint
Replacement Registry (AOANJRR) now classifies them in a
separate medial pivot design category, and they accounted
for 7% of the primary TKAs in Australia in 2017 [18].
Despite the growth in use of the medial pivot design,
there is little knowledge of the longevity of these implants
as a group or of different brands. Most studies are smaller
clinical studies on the longevity of the Advance MP [21,
24, 36], or smaller clinical or fluoroscopic studies on the
different implants’ function [19, 35, 38]. To our knowl-
edge, there have been no larger registry studies that address
the survival of medial pivot implants before this study.
We used the databases of the AOANJRR and
Norwegian Arthroplasty Register (NAR) to ask the fol-
lowing questions: (1) Is there any difference in survival
between the medial pivot design and the three most com-
monly used cruciate-retaining TKA designs? (2) Is there
any difference in survival among the different medial pivot
implant designs? (3) What are the main indications for
revision of medial pivot TKAs?
Patients and Methods
Study Design and Setting
This study derived its data from two national registries, the
NAR and AOANJRR. From those, we identified all medial
pivot TKAs from 2005 until the end of 2017.We compared
these with a control group of the threemost commonly used
cruciate-retaining designs of TKA in Norway and
Australia. The NAR began registering TKA data in 1994
[14, 15] and the AOANJRR began registering data 1999.
Both registries have a completeness of 99% and 98%, re-
spectively [11, 18]. Emigration from both countries was
negligible in the elderly [2, 30].
Participants
Datasets from Australia and Norway from 2005 through
2017 (Fig. 1) were merged by creating common endpoints
using the Australian hierarchy of revision diagnoses [18]. In
Australia, the study group of implants (medial pivot) in-
cluded the Evolution MP, the MRK, the SAIPH, the GMK
Sphere, the Advance MP II, which represented 9% (6012 of
72,477) of the total number of TKAs with cemented tibias
without patella resurfacing; 345 had cementless femoral
components. InNorway, only theAdvanceMP II, Evolution
MP, and GMK Sphere were used during this period and
represented 1% (298 of 47,820) of the total number of TKAs
with cemented tibias without patella resurfacing, all with
cemented femoral components. We thus included only
fixed-bearing prostheses with cemented tibial components
in TKA without patella resurfacing. The control group
consisted of the three most commonly used fixed-bearing,
cruciate-retaining TKA implants with a cemented tibial
component in each country. This comparison group was
chosen as fixation with or without cement for the femoral
component yields equivalent survival [18]. Themedial pivot
design was primarily developed to mimic native knee mo-
tion to improve function, and not as a constrained knee for
difficult cases. This is, however, likely the case for many of
the posterior-stabilized TKA designs used in the registries
(10% and 23% of the total number of primary TKAs in
Norway and Australia respectively) [14, 18]. The control
group therefore consisted of cemented tibia and uncemented
or cemented femoral components from NexGen® CR
(Zimmer Biomet, Warsaw, IN, USA), Triathlon® Total
Knee System (Stryker, Mahwah, NJ, USA) and Legion
Total Knee System (Smith and Nephew, Memphis, TN,
USA) from Norway (n = 16,316) and NexGen® CR, PFC®
Sigma® (DePuy Orthopaedics Inc, Warsaw, IN, USA), and
Triathlon® Total Knee System from Australia (n = 54,554).
Patellar resurfacing is rarely performed in Norway, but the
survival of both medial pivot and cruciate-retaining TKA
designs has been shown to improve with patellar resurfacing
[18]. In Sweden, about 2% of TKAs have the patella
resurfaced [33], and The National Joint Registry of England
and Wales reported 42% of their TKAs have resurfaced
patellae [26]. In addition, for the medial pivot as a group
reported in the AOANJRR, 47% (6740 of 14,421) of the
TKAs did not have a resurfaced patella. In fact, 2017was the
only year in our study period (2005-2017) that patellar
resurfaced TKAS outnumbered un-resurfaced patellar
TKAs [18]. To minimize confounding because of the
changing proportion of patellar component use over time,
we therefore excluded all patients with patella resurfacing.
Variables, Outcome Measures, Data sources, and Bias
Our primary study endpoint for our first question was to
determine if there was a difference in survival between the
medial pivot design and the three most commonly used
cruciate-retaining TKA designs. We investigated this by
assessing the Kaplan-Meier estimates of survivorship, and
compared the groups by calculating the hazard ratios using
Cox regression. We used this approach for our second
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question as well. For our third question, we calculated the
percentage of each revision indication of the total number of
revisions in each group for both nations. In addition, we
calculated hazard ratios of the different revision causes, based
on the Australian hierarchy of revisions [18]. To limit bias,
we adjusted for gender, age, and preoperative diagnosis.
Demographics, Description of Study Population
The proportion of men in the study group was almost
identical between the two databases (48% in the NAR
versus 49% in the AOANJRR) (Table 1), whereas in the
control group, there was a difference in the proportion of
men between the databases (40% in the NAR versus 44%
in the AOANJRR; p < 0.001). The mean ages in the study
group (NAR, 68 years; AOANJRR, 68 years) and control
group (NAR, 69 years; AOANJRR, 69 years) were com-
parable. The proportion of patients with a preoperative
diagnosis of osteoarthritis differed between the coun-
tries (study group NAR 92% versus AOANJRR 99%;
p < 0.001; control group NAR 92% versus AOANJRR
99%; p < 0.001).
As the Advance MP I was reported in the AOANJRR as
having an unfavorable result [18], we reviewed all of the
catalog numbers of this implant in both countries; only four
such tibial implants were used in Australia from 2005 to
2017.The remainingAdvanceMP implants inAustralia and all
implants inNorwaywereAdvance®MP II implants (Table 2).
Advance MP I was thus excluded from further analyses.
Statistical Analysis, Study Size
We used the chi-square test to compare dichotomous data
(that is, gender and preoperative diagnosis) and a two-sided
t-test for continuous distributed data (age differences). P
values < 0.05 were regarded as statistically significant.
Kaplan-Meier estimates of implant failure are clinically
meaningful and straightforward to interpret for clinicians,
and recommended by the Nordic Arthroplasty Register
Association (NARA) study group [32] and used by theNAR
Fig. 1 This flowchart shows the patients who were included in the study; NAR = the
NorwegianArthroplasty Register, AOANJRR = the Australian Orthopaedic Association National
Joint Replacement Registry. *Three most used cruciate-retaining and all-medial pivot TKAs.
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[14]. The AOANJRR uses the complement to this, the cu-
mulative percent revision [18]. In the AOANJRR, Kaplan-
Meier estimates were made for 9-year survival stratified by
group and country, and 3-year and 9-year survival bymedial
pivot brand. Survival tables and curves were constructed. A
Cox regression analysis of the groups, stratified by country
with revision for any cause, and analysis for competing risk
from death using the methods of Fine and Gray [12], was
also performed.We also performed Cox regression analyses
to investigate causes of revision and HR in Norway and
Australia. Whenever crossing curves were displayed, we
performed individual Cox regression analyses before and
after they intersected to test whether the assumption of
proportional hazards could be applied. Cox regression
analyses of themain reasons for revision ofmedial pivot and
cruciate-retaining implants in Norway and Australia were
also performed. TheAdvanceMP is under special follow-up
in the AOANJRR, so we also constructed plots and Cox
regression analyses of the study group without this implant.
Many medial pivot implant revisions in Australia were
performed for patella erosion or pain alone. For this reason,
we performed a sensitivity analysis for Australia excluding
all revisions for these two diagnoses whenever the revision
involved a secondary patella insertion only or patella in-
sertion and exchange of the insert. For Australia, we also
performed Cox regression analyses of the individual medial
pivot implants, with the cruciate-retaining group as a con-
trol. Such an analysis was not possible for the implants
reported in the NAR because of the low number of cruciate-
retaining implants. All Cox regression analyses and Kaplan-
Meier estimates are given with 95% CIs, the former always
adjusted for age, gender, and preoperative diagnosis. SPSS®
Statistics version 25 (IBMCorp, Armonk, NY, USA) and R
version 3.5.3 (The R Foundation for Statistical Computing,
Vienna, Austria) was used for the statistical analyses.
Results
Is There Any Difference in the Survival Rate Between
Medial Pivot and Cruciate-retaining TKAs?
The medial pivot group had poorer survivorship than the
cruciate-retaining group in Australia. After controlling for
potential confounding variables such as age, gender and
preoperative diagnosis, we found an increased HR for re-
vision for any cause for medial pivot designs compared
with cruciate-retaining TKAs in Australia (HR 1.4 [95%CI
1.2 to 1.7]; p < 0.001) but not in Norway (HR 1.5 [95% CI
0.9 to 2.4]; p = 0.1) (Table 3). The Fine and Gray analysis
with death as the competing risk was identical [12]. In
Australia, the Kaplan-Meier 9-year survival with revision
for any cause was 94.8% (95% CI 93.4 to 96.3) for the
medial pivot designs and 96.4% (95% CI 96.2 to 96.6) for
cruciate-retaining TKAs (Fig. 2). In Norway, the corre-
sponding survival for the medial pivot designs was 92.2%
Table 1. Demographics of the study and control groups
Variable
Study group: medial pivot designs
p value










Men (%) 48 48 0.9 40 43 < 0.001
Age (years),
mean 6 SD
68 6 10 68 6 9 0.6 69 6 10 69 6 9 0.8
Diagnosis (%)
Osteoarthritis 92 99 < 0.001 92 99 < 0.001
Other 8 2 9 1
Table 2. Number of implants by group and by brand in Norway and Australia






GMK® Sphere 31 2122 Triathlon® CR 2519 25,604
Advance® MP 0 4 Legion® CR 2703
Advance® II MP 216 492 NexGen® CR 11,094 19,378
MRK™ 0 425 PFC® Sigma® 9572
SAIPH® 0 834 Total cruciate-retaining 16,316 54,554
Evolution® MP 51 2135
Total medial pivot 298 6012
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(95% CI 89.0 to 95.4) and for the cruciate-retaining it was
94.5% (95% CI 93.8 to 95.2) (Fig. 3). The Kaplan-Meier
survival curves of Norway crossed at 1.7 years (Fig. 4A).
The HR before this time point (0.5 [95% CI 0.1 to 2.1]; p =
0.4) and after (2.1 [95% CI 1.2 to 4.0]; p = 0.02) was
therefore calculated (Fig. 4B).
Is There Any Difference in Survival Between the
Different Medial Pivot Implants?
There were prosthesis-specific differences in revision rates
(Table 4). In Australia, the Advance MP II had a higher all-
cause revision than cruciate-retaining implants (HR 1.7
[95% CI 1.2 to 2.6]; p < 0.004) (Fig. 5A). The same was
true for the GMK Sphere (HR 2.0 [95% CI 1.5 to 2.6]; p <
0.001) (Fig. 5B). There was no difference in the HRs of the
EvolutionMP (1.4 [95% CI 1.0 to 1.9]; p = 0.06) (Fig. 5C),
the MRK (0.7 [95% CI 0.4 to 1.5]; p = 0.4) (Fig. 5D), and
the SAIPH (0.9 [95% CI 0.5 to 1.5]; p = 0.7) (Fig. 5E). The
Kaplan-Meier plot of the medial pivot in the AOANJRR,
excluding the Advance MP II, showed an HR of 1.4 (95%
CI 1.1 to 1.7; p < 0.001) (Fig. 6).
What Are the Main Reasons for Revision of Medial
Pivot TKA?
In Norway, the most frequent reasons for revision in the
medial pivot groupwere lysis or loosening (28%, five of 18),
instability (28%, five of 18), malalignment (11%, two of 18)
and pain alone (11%, two of 18), while in Australia, they
were infection (27%, 39 of 142), pain alone (19%, 27 of
142), patella erosion (13%, 19 of 142) and loosening (12%,
17 of 142) (Table 5). By comparison, the reasons for revision
in Norway for the cruciate-retaining group were infection
(34%, 176 of 519), instability (19%, 97 of 519), malalign-
ment (13%, 70 of 519), and pain alone (12%, 64 of 519). In








































































































































































































































































































































































































































































































































































































Fig. 2 This graph shows survival functions of the medial pivot
and cruciate-retaining designs in Australia. Curves end when
20 patients are left at risk.
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333 of 1324), lysis or loosening (15%, 199 of 1324) and
patella erosion (10%, 130 of 1324) were the most frequent
reasons for revision in the control group. The sensitivity
analysis did not affect the HR for Australia (HR 1.5 [95%CI
1.2 to 1.9]; p < 0.001) (Fig. 7). Stratified by the reasons for
revision, for Australia, we found there was an increased risk
of revision in the medial pivot group for malalignment (HR
4.9 [95% CI 1.9 to 12.5]; p < 0.001), instability (HR 1.9
[95% CI 1.1 to 3.4]; p = 0.03), and patella erosion (HR 2.2
[95% CI 1.4 to 3.6]; p < 0.001) (Table 6). In Norway, there
was an increased risk for loosening or lysis (HR 4.7 [95%CI
1.8 to 12.0]; p < 0.001) (Table 3).
Discussion
Despite the increased usage of medial pivot implants as
documented in international registries, no registry studies
on this design as a group have been published to our
knowledge. We therefore performed this large registry
study to compare the survival of medial pivot TKAs with
the most-used cruciate-retaining implants in Norway and
Australia. Our main finding was that there was decreased
Kaplan-Meier survival of the medial pivot designs com-
pared with cruciate-retaining designs, although differences
between individual brands existed.
Limitations
Our study has several limitations. First, because it was a
national registry study, we cannot rule out selection bias,
with the medial pivot design potentially chosen for a more
active patient group. There were differences in gender
distribution and preoperative diagnosis, but the Cox re-
gression analysis adjusted for these differences. Second,
although we adjusted for the preoperative diagnosis, we did
not have any information about the severity of osteoar-
thritis or extent of preoperative malalignment. In the
AOANJRR [18], more than 23% of all TKAs were
posterior-stabilized designs, which are often preferred for
more difficult procedures [33]. Theoretically, the medial
pivot could be used as a substitute for posterior-stabilized
designs in such cases, and this might partly explain the
difference in HR. Third, we did not adjust for hospital or
surgeon volume. Because medial pivots are newer
implants, there might be more of a learning curve than with
the cruciate-retaining design. Fourth, there was an uneven
distribution of prosthesis types between the countries. The
difference between the Advance MP I and II was the
locking mechanism of the tibial insert [13]. In Norway,
almost all medial pivot implants were the Advance MP II.
Fig. 4 A-B These graphs show (A) the survival function of the medial pivot and cruciate-retaining designs in Norway and (B) after
crossing of the curves at 1.68 years. Curves end when 20 patients are left at risk
Fig. 3 This graph shows the survival function of the medial
pivot and cruciate-retaining designs in Norway and Australia.
Curves end when 20 patients are left at risk.
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As stated earlier, the Advance® MP I was reported to have
an inferior performance in the AOANJRR [18], so if sim-
ilar performance plagues the Advance MP II, this could
affect the survival and HR of the medial pivot group in
Norway. The lack of findings in the Norwegian data could,
of course, be partly explained by the small number of
medial pivoting implants. Fifth, this study considered only
survivorship and did not include patient-reported outcome
measures, which may be a more sensitive method of de-
termining outcome differences and patient satisfaction.
This was simply because we did not have this information.
Furthermore, like most revision studies, the study does not
account for those who may be candidates for revision, but
who have too many comorbidities to undergo surgery or
are awaiting surgery. Sixth, we only included TKAs with
un-resurfaced patellae. This could affect the external
Fig. 5 These graphs show the survival function of the (A) Advance® II MP, (B) the GMK® Sphere, (C) the Evolution® MP, (D) the MRK™,
and (E) the SAIPH® versus cruciate-retaining in Australia. Curves end when 20 patients are left at risk.
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(95% CI) Left at risk
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Advance® II MP 1.7d
(1.2 to 2.6)



























Hazard ratio by arevision for any cause and blysis or loosening of medial pivot brands compared to minimally dtabilized (NexGen®
CR, Triathlon® CR and PFC® Sigma®) (dreference HR = 1) controls in Australia. eKaplan-Meier survival estimates for 3 and 9 years when
20 or more implants were left at risk.
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validity of the study, but only in countries where resur-
facing is done more or less by default for reasons stated
earlier [14, 18, 33]. One study recently implied that post-
operative retropatellar pressure is low in medial pivot
implants [17], yet our study showed there is an increased
risk for revision due to patellar erosion.
Is There Any Difference in the Survival Rate Between
Medial Pivot and Cruciate-retaining TKAs?
Medial pivot implants have a higher revision risk than
cruciate-retaining implants do in Australia for primary
cemented TKAs without patella resurfacing. We found no
such difference in Norway, and the confidence intervals
were very wide. To our knowledge, there have been no
larger registry or clinical studies on the medial pivot design
TKA as a group. There was one smaller registry study [5],
and one review article [13], but they assessed only the
Advance MP and in a limited number of patients. Both
studies concluded with excellent survival results.
Furthermore, one other review article assessed medial
pivot implants [44], but this also included primarily studies
on the Advance MP. They compared the medial pivot de-
sign with non-medial stabilized design and were “unable to
reach a clear conclusion in the clinical performance of
medial stabilized knee replacement construct” [44]. Only
three studies included in this review were not on the
Advance MP, and only one was a high-quality study on the
MRK™ [19]. Our study is to date the most comprehensive
study on the matter, and therefore, we think it adds sub-
stantial knowledge to the field of interest; however, the
results should be treated with caution because the follow-
up period for most of the implants was short.
Is There Any Difference in Survival Between the
Different Medial Pivot Implants?
In the analysis of individual implants, the AdvanceMP II and
the GMK Sphere had a higher revision risk than the other
implants, the latter at only 3 years of follow-up. The
Evolution MP, the SAIPH, and the MRK, in contrast, have
survival results similar to the three most-used cruciate-
retaining implants inAustralia. The SAIPH and theMRKhad
some revisions within the first 2 years of implantation, but no
further revisions in the time frame studied, in contrast to the
AdvanceMP II, the GMKSphere and the EvolutionMP. The
latter three continue to have documented revision surgery
after 2 years postoperatively (Fig. 5). The Advance MP I has
Table 5. Reason for revision of medial pivot and cruciate-
retaining implants in Norway and Australia following the




Norway Australia Norway Australia
n = 298 n = 6012 n = 16,316 n = 54,554
Not revised (n) 280 5870 15,797 53,230
Total number
revised (%)
18 (6) 142 (2) 519 (3) 1324 (2)
Infection 1 (6) 39 (27) 176 (34) 333 (25)
Malalignment 2 (11) 6 (4) 70 (13) 17 (1)
Loosening or lysis 5 (28) 17 (12) 43 (8) 199 (15)
Instability 5 (28) 13 (9) 97 (19) 97 (7)
Pain alone 2 (11) 27 (19) 64 (12) 393 (30)
Patella erosiona 0 (0) 19 (13) 3 (1) 130 (10)
Otherb 3 (16) 21 (15) 66 (13) 155 (12)
Numbers in parentheses are the percentage of all revisions in
each category.
aPatella erosion or progression of disease.
bOther means the remaining reasons for revision are not listed
here; AOANJRR = Australian Orthopaedic Association National
Joint Replacement Registry.
Fig. 7 This graph shows the sensitivity analysis for Australia.
All revisions for “pain alone” and “patella erosion” and minor
revision surgery for “patella only” or “patella/insert” combined
were excluded before the Cox regression analysis. Curves end
when 20 patients are left at risk.
Fig. 6 This graph shows the survival function of the MP =
medial pivot design, excluding the Advance® MP, versus cru-
ciate-retaining design in Australia. Curves end when 20
patients are left at risk.
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been shown to have a higher-than-anticipated revision rate
[18], and we therefore excluded the Advance MP II from the
Cox regression analysis. This did not affect the relative risk of
themedial pivot as a group. One explanation for this could be
that the total number of Advance MP II implants accounted
for only 8% of the medial pivot implants used between 2005
and 2017, and thus had a relatively low impact on the overall
results. There have been numerous studies on these in-
dividual implants. Some have suggested the in vivo kine-
matics of their design are like the native knee [38, 39], but
some of the studies included very few patients [23, 37].
Smaller survivorship studies also show they have good-to-
excellent survivorship [22] and patient satisfaction [34], but
others report they do not have better functional results than
other designs [43]. The National Joint Registry for England,
Wales, Northern Ireland and the Isle of Man (NJR) report
excellent results of the MRK, and good results of the
Advance MP. In their report they did not discriminate be-
tween Advance MP I and II [26]. Despite numerous studies
on the design, ours is the first to document inferior results
with the Advance MP II and the GMK Sphere. It therefore
highlights a gap in the documentation on the different medial
pivot implants because we do not know the reason why they
perform differently. Further studies are thus necessary.
What Are the Main Reasons for Revision of Medial
Pivot TKA?
The main reasons for revision in absolute numbers, in the
medial pivot group in Norway were lysis or loosening, in-
stability, malalignment, and pain alone. The total number of
revisions was, however, very small. In Australia, the main
reasons in absolute numbers were infection, pain alone, pa-
tella erosion, and loosening/lysis. Infection, loosening/lysis,
and pain alone are frequent reasons for revision of cruciate-
retaining implants in the AOANJRR as well. In terms of
Kaplan-Meier survival, only patella erosion as a revision
indication showed poorer survival. All of these are frequent
and well-known reasons for TKA revision [14, 18, 31], al-
though the main indications differ in other reports [40].
However, we documented a near fivefold risk of revision for
malalignment, and a doubled risk of revision for instability in
Australia for medial pivot designs compared with cruciate-
retaining implants. Some reports indicate that medial pivot
design improve patellofemoral biomechanics [1, 17, 42],
possibly due to the lack of medial translation and the lateral
femoral rollback [39]. However, other studies fail to report
this [7].We excluded all primary resurfaced patellar implants
fromour study, and therefore performed a sensitivity analysis
to examine whether there was a change in the HR when we
excluded secondary patella insertions combined with patella
erosion or pain alone as revision indications. This did not
affect the HR.We do not think that the status of the patella in
terms of resurfacing affected the relative risk of revision for
malalignment and instability. Therefore, it is likely that this
finding applies for all medial pivot design TKA procedures,
regardless of resurfacing. Although all the medial pivot
implants in the study were cruciate-sacrificing, they still have
no post-cam mechanism and are dependent on the medial
femoral condyle resting snugly in the congruent insert for
appropriate kinematics. If this is not achieved, instability
might partially explain the higher revision risk due to patella
erosion and subsequent increased forces on the patella. The
medial congruency of these implants could in theory also
lead to loosening [16, 41].
Conclusions
This large registry study that captured data from two
countries between 2005 and 2017 showed that the medial
pivot TKA design as a group had a higher revision rate than
cruciate-retaining fixed-bearing controls in TKA
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Infection 0.3 (0.0 to 1.9) 0.2 1.3 (0.9 to 1.8) 0.1
Malalignment 1.0 (0.3 to 4.3) 1.0 4.9 (1.9 to 12.5) < 0.001
Instability 2.1 (0.9 to 5.2) 0.1 1.9 (1.1 to 3.4) 0.03
Pain alone 1.4 (0.3 to 5.6) 0.7 1.0 (0.7 to 1.5) 1.0
Patellar erosionb c c 2.2 (1.4 to 3.6) 0.001
aCruciate-retaining controls have HR = 1 for the various revision causes.
bPatellar erosion or disease progression.
cNo operations for this indication were performed in Norway.
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performed without patellar component resurfacing. By
brand, the Advance II MP and the GMK Sphere had in-
ferior survivorship, whereas the MRK, SAIPH and the
EvolutionMP had no differences in survivorship compared
with cruciate-retaining controls. In Australia, TKAs with
the medial pivot design without patella resurfacing had a
higher rate of revisions for instability, malalignment, and
patella erosion. In Norway, there was an increased risk of
lysis and loosening compared with those with the cruciate-
retaining design. Several of these implants had short
follow-up in this study. Further registry studies with longer
follow up are therefore necessary.
This is an open-access article distributed under the terms of the
Creative Commons Attribution-Non Commercial-No Derivatives
License 4.0 (CCBY-NC-ND), where it is permissible to download
and share the work provided it is properly cited. The work cannot be
changed in any way or used commercially without permission from
the journal.
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